Home › Funds › Eiger Wealth Management, LLC › ZNTL

Eiger Wealth Management, LLC position in ZNTL

Zentalis Pharmaceuticals Inc · Health Care

Eiger Wealth Management, LLC reported holding 115,112 shares of ZNTL (Zentalis Pharmaceuticals Inc) in its Q3 2026 13F filing — a position valued at US$319K, representing 6.90% of its reported portfolio and ranking #4 among its reported holdings. Eiger Wealth Management, LLC has disclosed ZNTL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)115.11K sh
Reported value held$318.86K
Portfolio Weight6.90%
First reportedQ4 2025
Last changeAdd
Updated2026-11-07

Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR

How Eiger Wealth Management, LLC's ZNTL position evolved

Eiger Wealth Management, LLC first disclosed a stake in ZNTL in Q4 2025 at 86,017 shares (US$116K). The position peaked in Q2 2026 at 86,017 shares, worth US$417K. Across 4 filings, Eiger Wealth Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 115,112 shares valued at US$319K — an increase of 29,095 shares quarter over quarter.. Notable position changes include a 34% increase in Q3 2026 (shares fell 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 86.02K $116.12K New
Q1 2026 86.02K $201.28K Hold
Q2 2026 86.02K $417.18K Hold
Q3 2026 115.11K $318.86K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZNTL and 13F data

ZNTL (Zentalis Pharmaceuticals Inc) is a Health Care company. 30 other funds we track also report a position in ZNTL — the largest reported positions include 5AM Venture Management, LLC (US$19.1M), Opaleye Management Inc. (US$6.9M), Decheng Capital LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZNTL

All ZNTL fund holders →

FAQ

How long has Eiger Wealth Management, LLC held ZNTL?

Eiger Wealth Management, LLC has disclosed ZNTL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Eiger Wealth Management, LLC's current position in ZNTL?

As of Q3 2026, Eiger Wealth Management, LLC holds 115.11K shares of ZNTL (Zentalis Pharmaceuticals Inc), valued at $318.86K, representing 6.90% of its reported portfolio and ranking #4.

Has Eiger Wealth Management, LLC been buying or selling ZNTL?

In the latest 13F filing (Q3 2026), Eiger Wealth Management, LLC increased its position in ZNTL. The position peaked in Q2 2026 at 86.02K shares.

Which other funds hold ZNTL?

Other major institutional holders of ZNTL include 5AM Venture Management, LLC, Opaleye Management Inc., Decheng Capital LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.